Delayed postprandial retinyl palmitate and squalene removal in a patient heterozygous for apolipoprotein A-IFIN mutation (Leu 159-->Arg) and low HDL cholesterol level without coronary artery disease

Atherosclerosis. 1996 Dec 20;127(2):239-43. doi: 10.1016/s0021-9150(96)05961-8.

Abstract

A low HDL cholesterol level is frequently but not consistently associated with inefficient postprandial fat clearance. We studied triglycerides, retinyl palmitate and squalene and apolipoprotein B-48 after a fat loading test in one subject heterozygous for a novel point mutation of apolipoprotein A-I (A-IFIN, Leu 159-->Arg) and low HDL cholesterol level without coronary artery disease, and in 16 healthy controls with the same apolipoprotein E phenotype, 3/3, as the proband. HDL cholesterol and apolipoprotein A-I levels were 0.32 mmol/l and 57 mg/dl in the proband, and 1.29 +/- 0.12 mmol/l (mean +/- S.E.) and 126 +/- 4 mg/dl in the controls. The peak concentration for triglycerides in plasma, chylomicrons and VLDL occurred at 4 h both in the case and controls. However, the peak concentrations for retinyl palmitate and squalene in chylomicrons and VLDL were delayed to 12 h in the proband compared with 4 and 9 h in the controls. The peak of apolipoprotein B-48 occurred at 6 h in the proband and at 4 h in the controls, so that triglycerides, apolipoprotein B-48 and retinyl palmitate and squalene peaked differently. After 24 h, retinyl palmitate, squalene, and apolipoprotein B-48 had returned to the baseline levels. The results show for the first time an impaired postprandial lipoprotein removal in a case heterozygote with moderately low HDL cholesterol due to an apolipoprotein A-1 mutation not associated with coronary artery disease.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Anticarcinogenic Agents / blood*
  • Apolipoprotein A-I / blood
  • Apolipoprotein A-I / genetics*
  • Apolipoprotein B-48
  • Apolipoproteins B / blood
  • Cholesterol, HDL / blood*
  • Cholesterol, VLDL / blood
  • Chromatography, Gas
  • Chylomicrons / metabolism
  • Coronary Disease / blood
  • Dietary Fats / administration & dosage
  • Diterpenes
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Heterozygote
  • Humans
  • Middle Aged
  • Point Mutation*
  • Postprandial Period*
  • Retinyl Esters
  • Risk Factors
  • Squalene / blood*
  • Triglycerides / blood
  • Vitamin A / analogs & derivatives*
  • Vitamin A / blood

Substances

  • Anticarcinogenic Agents
  • Apolipoprotein A-I
  • Apolipoprotein B-48
  • Apolipoproteins B
  • Cholesterol, HDL
  • Cholesterol, VLDL
  • Chylomicrons
  • Dietary Fats
  • Diterpenes
  • Retinyl Esters
  • Triglycerides
  • Vitamin A
  • retinol palmitate
  • Squalene